Clinical Trial Update: A Prospective, Observational Study in Patients With Late-Onset Pompe Disease

View source ↗

Summary

This clinical trial update notes the completion of a prospective, observational study in patients with late-onset Pompe disease (Glycogen Storage Disease Type I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type Ii

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Glycogen Storage Disease Type II | Status: COMPLETED